Bradykinin Receptors Play a Critical Role in the Chronic Post-ischaemia Pain Model

• Published in: Cellular and molecular neurobiology Vol. 41; no. 1; pp. 63 - 78
• Main Authors: Gonçalves, Elaine C. D., Vieira, Graziela, Gonçalves, Tainara R., Simões, Róli R., Brusco, Indiara, Oliveira, Sara M., Calixto, João B., Cola, Maíra, Santos, Adair R. S., Dutra, Rafael C.
• Format: Journal Article
• Language: English
• Published: New York Springer US 2021; Springer Nature B.V
• Subjects: Agonists; Antisense oligonucleotides; Biomedical and Life Sciences; Biomedicine; Bradykinin; Bradykinin receptors; Cell Biology; Chronic pain; Complex regional pain syndrome; Edema; Gene expression; Hyperalgesia; Inflammation; Ischemia; Neurobiology; Neurosciences; Original Research; Pain; Pain perception; Spinal cord; Trauma; Kinins; Inflammation; Inflammatory mediators; Bradykinin receptor antagonists; Chronic pain; Hyperalgesia
• ISSN: 0272-4340; 1573-6830
• DOI: 10.1007/s10571-020-00832-3

Complex regional pain syndrome type-I (CRPS-I) is a chronic painful condition resulting from trauma. Bradykinin (BK) is an important inflammatory mediator required in acute and chronic pain response. The objective of this study was to evaluate the association between BK receptors (B 1 and B 2 ) and chronic post-ischaemia pain (CPIP) development in mice, a widely accepted CRPS-I model. We assessed mechanical and cold allodynia, and paw oedema in male and female Swiss mice exposed to the CPIP model. Upon induction, the animals were treated with BKR antagonists (HOE-140 and DALBK); BKR agonists (Tyr-BK and DABK); antisense oligonucleotides targeting B 1 and B 2 and captopril by different routes in the model (7, 14 and 21 days post-induction). Here, we demonstrated that treatment with BKR antagonists, by intraperitoneal (i.p.), intraplantar (i.pl.), and intrathecal (i.t.) routes, mitigated CPIP-induced mechanical allodynia and oedematogenic response, but not cold allodynia. On the other hand, i.pl. administration of BKR agonists exacerbated pain response. Moreover, a single treatment with captopril significantly reversed the anti-allodynic effect of BKR antagonists. In turn, the inhibition of BKRs gene expression in the spinal cord inhibited the nociceptive behaviour in the 14th post-induction. The results of the present study suggest the participation of BKRs in the development and maintenance of chronic pain associated with the CPIP model, possibly linking them to CRPS-I pathogenesis.